Indication And NotWilliam Ondo
List of bibliographic references
Number of relevant bibliographic references: 32.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000968 | Markus Naumann [Allemagne] ; Alastair Carruthers [Canada] ; Jean Carruthers [Canada] ; Sheena K. Aurora [États-Unis] ; Ross Zafonte [États-Unis] ; Susan Abu-Shakra [États-Unis] ; Terry Boodhoo [États-Unis] ; Mary Ann Miller-Messana [États-Unis] ; George Demos [États-Unis] ; Lynn James [États-Unis] ; Frederick Beddingfield [États-Unis] ; Amanda Vandenburgh [États-Unis] ; Mary Ann Chapman [États-Unis] ; Mitchell F. Brin [États-Unis] | Meta-Analysis of Neutralizing Antibody Conversion with OnabotulinumtoxinA (BOTOX®) Across Multiple Indications |
| 000D58 | David Devos [France] | Patient Profile, Indications, Efficacy and Safety of Duodenal Levodopa Infusion in Advanced Parkinson's Disease |
| 002080 | Carla Cordivari [Royaume-Uni] ; V. Peter Misra [Royaume-Uni] ; Santiago Catania [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | New therapeutic indications for botulinum toxins |
| 002272 | Dopamine transporter imaging | |
| 002317 | Klaus L. Leenders [Pays-Bas] | Significance of non-presynaptic SPECT tracer methods in Parkinson's disease |
| 002331 | Vicky Marshall [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders |
| 002332 | Vicky Marshall [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Role of dopamine transporter imaging in routine clinical practice |
| 002333 | Werner Poewe [Autriche] ; Christoph Scherfler [Autriche] | Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice |
| 002334 | Wolfgang H. Oertel [Allemagne] ; Anja Gerstner [Allemagne] ; Helmut Höffken [Allemagne] ; Richard C. Dodel [Allemagne] ; Karla M. Eggert [Allemagne] ; Jens C. Möller [Allemagne] | Role of dopamine transporter SPECT for the practitioner and the general neurologist |
| 002380 | Bechir Jarraya [France] ; Anne-Marie Bonnet [France] ; Charles Duyckaerts [France] ; Jean-Luc Houetc [France] ; Philippe Cornu [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] | Parkinson's disease, subthalamic stimulation, and selection of candidates: A pathologic study |
| 002436 | Paul K. Morrish [Royaume-Uni] | How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease? |
| 002493 | Durval C. Costa [Royaume-Uni, Portugal] ; Zuzana Walker [Royaume-Uni] ; Rodney W. H. Walker [Royaume-Uni] ; Flavia R. G. Fontes [Royaume-Uni] | Dementia with Lewy bodies versus alzheimer's disease: Role of dopamine transporter imaging |
| 002500 | Eduardo Tolosa [Espagne] ; Miguel Coelho [Espagne] ; Marisol Gallardo [Espagne] | DAT imaging in drug-induced and psychogenic parkinsonism |
| 002595 | Surgical treatment for Parkinson's disease: Neural transplantation | |
| 002596 | Surgical treatment for Parkinson's disease: Deep brain surgery | |
| 002603 | Johannes D. Speelman [Pays-Bas] ; Richard Schuurman [Pays-Bas] ; Rob M. A. De Bie [Pays-Bas] ; Rianne A. J. Esselink [Pays-Bas] ; D. Andries Bosch [Pays-Bas] | Stereotactic neurosurgery for tremor |
| 002705 | Levodopa | |
| 002716 | Paul Morrish [Royaume-Uni] | Is it time to abandon functional imaging in the study of neuroprotection? |
| 002808 | DA agonists: ergot derivatives: Bromocriptine | |
| 002813 | DA agonists: Ergot derivatives: Pergolide | |
| 002A88 | D. Dressler [Allemagne] ; M. Wittstock [Allemagne] ; R. Benecke [Allemagne] | Treatment of persistent hemiballism with botulinum toxin type A |
| 002C57 | Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Apomorphine : An underutilized therapy for Parkinson's disease |
| 002E48 | P. Hagell [Suède] ; H. Widner [Suède] | Clinical rating of dyskinesias in Parkinson's disease : Use and reliability of a new rating scale |
| 002F14 | J. D. Speelman [Pays-Bas] ; P. R. Schuurman [Pays-Bas] ; R. M. A. De Bie [Pays-Bas] ; D. A. Bosch [Pays-Bas] | Thalamic surgery and tremor |
| 002F15 | N. Syed [États-Unis] ; J. Murphy [États-Unis] ; T. Jr Zimmerman [États-Unis] ; M. H. Mark [États-Unis] ; J. I. Sage [États-Unis] | Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease |
| 002F22 | S. L. Pullman [États-Unis] | Spiral analysis : A new technique for measuring tremor with a digitizing tablet |
| 002F51 | P. G. Wasielewski [États-Unis] ; J. M. Burns [États-Unis] ; W. C. Koller [États-Unis] | Pharmacologic treatment of tremor |
| 002F73 | O. Pogarell [Allemagne] ; W. H. Oertel [Allemagne] | Neural transplantation in Parkinson's disease and its effects on rest tremor : A review of the literature |
| 002F81 | Alim-Louis Benabid [France] ; A. Benazzouz [France] ; D. Hoffmann [France] ; P. Limousin [France] ; P. Krack [France] ; Pierre Pollak [France] | Long-term electrical inhibition of deep brain targets in movement disorders |
| 002F89 | P. Krack [France] ; Pierre Pollak [France] ; P. Limousin [France] ; D. Hoffmann [France] ; A. Benazzouz [France] ; Alim-Louis Benabid [France] | Inhibition of levodopa effects by internal pallidal stimulation |
| 003546 | ||
| 003606 | G. K. Wenning [Royaume-Uni] ; R. J Ger [Royaume-Uni] ; B. Kendall ; D. Kingsley [Royaume-Uni] ; S. E. Daniel ; N. P. Quinn [Royaume-Uni] | Is cranial computerized tomography useful in the diagnosis of multiple system atrophy? |
| This area was generated with Dilib version V0.6.23. |  |